Concepedia

Shervin Assassi

SA

142

Publications

9.4K

Citations

59

H-Index

2005

Active since

Affiliations

The University of Texas Health Science Center at Houston(Current)

University of Michigan

University of California, Los Angeles

Northwestern University

Johns Hopkins University

Shervin Assassi is an author at The University of Texas Health Science Center at Houston specializing in medicine, scleroderma, and autoimmune disease.

ORCID

Top concepts

Publications per year

2005–2025

142

Publications

142

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1K citations · Full text

, , +9

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 449 citations · Full text

Systemic sclerosis and lupus: Points in an interferon‐mediated continuum

Shervin Assassi, Maureen D. Mayes, Frank C. Arnett et al. · Arthritis & Rheumatism · 2010 · 206 citations · Full text

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

Maureen D. Mayes, Lara Bossini‐Castillo, Olga Y. Gorlova et al. · The American Journal of Human Genetics · 2014 · 204 citations · Full text

, , +6

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

Kristin B. Highland, Oliver Distler, Masataka Kuwana et al. · The Lancet Respiratory Medicine · 2021 · 203 citations · Full text

, , +5

Rows per page

1–5 of 142